The heavy reliance on Mandragola for both acquisition financing and ongoing working capital, combined with the massive dilution from warrant exercises and note conversion, suggests Tessera is struggling to access traditional capital markets. Watch for additional draws on the new facility and whether the company seeks shareholder approval to exceed the 19.99% conversion cap — that would signal even deeper capital needs.
Price Chart
Executive Summary
Tessera Defense entered into a new $5M revolving credit facility with Mandragola Ltd. (in addition to an existing $2M facility), and concurrently issued 2,690,500 restricted shares to Mandragola via conversion of a prior note and cashless warrant exercises. The new facility is convertible into common stock at a floor of $1.00/share or a floating market-based price, capped at 19.99% of outstanding shares unless shareholder approval is obtained. The substantial dilution (2.69M shares on a post-issuance base of 8.92M shares, or ~30% of the new total) and the company's reliance on a single related-party lender for financing signal financial stress.
Key Financial Metrics
Key Facts
- New $5,000,000 revolving credit facility from Mandragola Ltd., on top of an existing $2,000,000 facility (no amounts outstanding under the prior facility as of the filing date).
- Between Sep 29 and Oct 2, 2026, the company issued 2,690,500 restricted shares to Mandragola: 200,000 shares upon conversion of $95,020 in principal at $0.4751/share, and 2,490,500 shares via cashless warrant exercises.
- Post-issuance shares outstanding: 8,920,240 (up from approximately 6,229,740 before these issuances, implying ~43% dilution from these transactions alone).
- The new credit line carries 12% simple interest, matures Oct 5, 2029, and is convertible at the lower of $1.00/share or the 5-day VWAP preceding conversion.
- Conversion is capped at 19.99% of outstanding shares unless stockholder approval is obtained; NYSE American must authorize a supplemental listing application before any conversion shares are issued.
- Mandragola is the same counterparty from whom the company acquired a 60% interest in Dr. Frucht Systems Ltd. in April 2026.
Financial Impact
Immediate dilution of ~43% from 2.69M new shares; potential for up to 19.99% additional dilution from the new $5M facility if fully converted at current prices. The company has access to up to $7M total credit (old + new facility) from a single related-party lender.
Risk Factors
- Massive dilution to existing shareholders from the 2.69M shares already issued and potential future conversion of the $5M facility.
- Related-party concentration risk — Mandragola is both a major lender and the seller of DFSL, creating potential conflicts of interest.
- High 12% interest rate on the new facility reflects distressed borrowing costs.
- NYSE American listing risk if the company cannot obtain stockholder approval for conversions exceeding 19.99%.
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-106872 |
| Document: ea030770901ex4-1.htm | 0001213900-26-106872 |
| Document: ea030770901ex10-1.htm | 0001213900-26-106872 |
| Document: 0001213900-26-106872-index-headers.html | 0001213900-26-106872 |
| Document: 0001213900-26-106872-index.html | 0001213900-26-106872 |
| Document: 0001213900-26-106872.txt | 0001213900-26-106872 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | 8-K | $0.2131 | awaiting T+5 | — | $0.2070 (+2.86%) |
Oct 19, 2026 8d ago | 8-K | $0.2335 $0.2073 | ▲ +11.22% | ▲ +11.30% | $0.2070 (+11.35%) |
Oct 13, 2026 14d ago | 8-K | $0.2382 $0.2390 | ▼ −0.34% | ▲ +0.12% | $0.2070 (+13.10%) |
Oct 8, 2026 19d ago | DEFA14A | $0.2850 $0.2230 | ▼ −21.75% | ▼ −19.79% | $0.2070 (−27.37%) |
Oct 8, 2026 19d ago | DEFA14A | $0.2850 $0.2230 | ▼ −21.75% | ▼ −19.79% | $0.2070 (−27.37%) |
Oct 6, 2026 21d ago | SC 13D/A | $0.3110 $0.2600 | ▼ −16.40% | ▼ −16.26% | $0.2070 (−33.44%) |
Oct 5, 2026 22d ago | SC 13G | $0.3110 $0.2600 | ▼ −16.40% | ▼ −16.26% | $0.2070 (−33.44%) |
Oct 5, 2026 22d ago | 8-K | $0.3110 $0.2600 | ▲ +16.40% | ▲ +16.26% | $0.2070 (+33.44%) |
Sep 25, 2026 4w ago | 8-K | $0.5280 $0.3600 | ▼ −31.82% | ▼ −31.60% | $0.2070 (−60.80%) |
Sep 22, 2026 5w ago | 8-K | $0.5500 $0.4008 | ▼ −27.13% | ▼ −26.45% | $0.2070 (−62.36%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers